Cardiac Metastasis of Cervical Cancer: A Case Report and Review of The Literature.

Heart Surg Forum

Department of Cardiovascular Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Published: April 2022

Background: Cervical cancer cardiac metastasis is a rare disease with a poor prognosis. It has been reported that the disease often is more detected at autopsy and has no standardized treatment options.

Case Presentation: Here, we report a patient with cardiac metastasis from cervical cancer who initially suffered nonspecific symptoms, such as chest tightness.

Conclusion: A review of cases of cardiac metastasis from cervical cancer in over a decade was performed. Pretreatment data were provided for such matters, which may be helpful for diagnosis and treatment in the future.

Download full-text PDF

Source
http://dx.doi.org/10.1532/hsf.4549DOI Listing

Publication Analysis

Top Keywords

cardiac metastasis
16
cervical cancer
16
metastasis cervical
12
cardiac
4
cervical
4
cancer
4
cancer case
4
case report
4
report review
4
review literature
4

Similar Publications

Cardiovascular Disease and Cancer: A Dangerous Liaison.

Arterioscler Thromb Vasc Biol

January 2025

Cardiovascular Research Center, New York University Langone Health, New York University Grossman School of Medicine. (A.A.C.N., J.M.D., K.J.M.).

The field of cardio-oncology has traditionally focused on the impact of cancer and its therapies on cardiovascular health. Mounting clinical and preclinical evidence, however, indicates that the reverse may also be true: cardiovascular disease can itself influence tumor growth and metastasis. Numerous epidemiological studies have reported that individuals with prevalent cardiovascular disease have an increased incidence of cancer.

View Article and Find Full Text PDF

A 65-year-old woman with a history of ductal mammary carcinoma and recent autonomic dysfunction underwent a Rb-82 chloride (RbCl) cardiac PET/CT scan that showed no ischemia or scarring, but significantly reduced myocardial flow reserve (MFR) (global: 1.5) and a CAC-Score of 0. The patient's chemotherapy history (paclitaxel, carboplatin, epirubicin, pembrolizumab 2 years before) with elevated Troponin T and NT-pro-BNP levels at that time, and now reduced MFR with 0 CAC suggests cancer-therapy-related cardiotoxicity.

View Article and Find Full Text PDF

Activation of the WNT4/ β-catenin/FOXO1 pathway by PDK1 promotes cervical cancer metastasis and EMT process.

J Mol Histol

January 2025

Department of Laboratory Medicine, Xiamen Key Laboratory of Genetic Testing, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, 55 Zhenhai Road, Siming District, Xiamen, 361003, Fujian, China.

Objective: This study aimed to elucidate the role of pyruvate dehydrogenase kinase-1 (PDK1) in cervical cancer (CC) by investigating its impact on cell proliferation, migration, and epithelial-mesenchymal transition (EMT) under hypoxic conditions.

Methods: PDK1-silenced CC cell lines were established using lentiviral shRNA technology. Cell migration and invasion were assessed through scratch and Transwell assays, respectively.

View Article and Find Full Text PDF

A 9-y-old, spayed female, non-brachycephalic mixed-breed dog was presented with progressive abdominal distension and diarrhea of <24 h duration. An echocardiogram revealed nodular masses in the pericardium and myocardium, particularly near the auricles. Diagnostic and therapeutic pericardiocentesis failed to improve the dog's status, and the owner elected euthanasia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!